About 3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one
3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one (PubChem CID 10312582) has the molecular formula C36H40ClF3N6O3
and a molecular weight of 697.20 g/mol. Its IUPAC name is 3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one.
Analyze 3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one?
The IUPAC name of 3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one (CID 10312582) is 3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one.
What is the SMILES notation for 3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one?
The canonical SMILES for 3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one is Nc1c(Cl)cc(CC(CC(=O)N2CCC(N3CCc4ccccc4NC3=O)CC2)c2nc3ccccc3n2CCCCO)cc1C(F)(F)F.
What is the InChIKey of 3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one?
The InChIKey is YQGLZLGWJWWOPH-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H40ClF3N6O3/c37-28-21-23(20-27(33(28)41)36(38,39)40)19-25(34-42-30-9-3-4-10-31(30)46(34)14-5-6-18-47)22-32(48)44-15-12-26(13-16-44)45-17-11-24-7-1-2-8-29(24)43-35(45)49/h1-4,7-10,20-21,25-26,47H,5-6,11-19,22,41H2,(H,43,49).
What are the key properties of 3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one?
3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one has a molecular weight of 697.20 g/mol, XLogP of 6.86, 10 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[1-[4-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-3-[1-(4-hydroxybutyl)benzimidazol-2-yl]butanoyl]piperidin-4-yl]-4,5-dihydro-1H-1,3-benzodiazepin-2-one is sourced from PubChem (CID 10312582), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).